Fundz

Bicycle Therapeutics plc raised $555 million in a private placement equity financing led by a U.S.-based healthcare focused investor for the development of precision-guided therapeutics.

PUBLIC · BCYCMay 23, 2024

Amount Raised

$555 Million

Round Type

Post-IPO Equity

BiotechnologyHealth CareTherapeuticsPharmaceutical

Investors

RA Capital ManagementPerceptive AdvisorsForbionFairmountEco R1 CapitalDeep Track Capital

Description

Bicycle Therapeutics plc announced a private placement equity financing of $555 million through a securities purchase agreement with certain existing and new accredited investors. The financing will be used to fund the continued development of its proprietary pipeline and for other research and development, as well as for general corporate purposes.

Quick answer

Bicycle Therapeutics raised $555 Million in a Post-IPO Equity round, dated May 23, 2024. Investors: RA Capital Management, Perceptive Advisors, Forbion, Fairmount, Eco R1 Capital and Deep Track Capital.

How much did Bicycle Therapeutics raise?
Bicycle Therapeutics raised $555 Million in a Post-IPO Equity round on May 23, 2024.
Who invested in Bicycle Therapeutics?
RA Capital Management, Perceptive Advisors, Forbion, Fairmount, Eco R1 Capital and Deep Track Capital are named as investors in this round.
What does Bicycle Therapeutics do?
Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of..
Where is Bicycle Therapeutics based and how big is it?
Fundz records about 316 employees.
Who are the decision-makers at Bicycle Therapeutics?
Fundz holds 1 contact at Bicycle Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Bicycle Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Virpax Pharmaceuticals raised $2.5M on July 5, 2024.
  • N-Power Medicine raised $72M (Series B) on July 1, 2024.
  • CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
  • CASI Pharmaceuticals raised $15M on June 26, 2024.
  • Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
  • Cerenome, Inc. raised $18M (Post-IPO Equity) on May 6, 2024.

Who to call at Bicycle Therapeutics, and when

A new round usually means Bicycle Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bicycle Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bicycle Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bicycle Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bicycle Therapeutics

About

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bicycle Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Bicycle Therapeutics's next move

See what Strategic adds

Bicycle Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.